A look at pharma and biotech financing, M&A, and stock market performance in 2023—and where developments may head next as company executives continue to navigate stormy but perhaps stabilizing waters in the months ahead.
Source link
#Industry #Business #Check #Market #Review #Rates #Latest #FullYear #Outputs
